|
1ZY3
Structural model of complex of Bcl-w protein with Bid BH3-peptide
Deposited 2005-06-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
82–101(20 aa)
|
Mutation:R203K
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;303 K;Ionic strength (raw mmCIF value) 10 mM NaCl;Pressure 1
NMR sample composition
0.7 mM Bcl-w U-15N,13C, 0.7 mM Bid BH3-peptide, 20 mM phosphate buffer, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.7 mM Bcl-w U-15N, 0.7 mM Bid BH3-peptide, 20 mM phosphate buffer, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.7 mM Bid BH3-peptide U-15N, 0.7 mM Bcl-w, 20 mM phosphate buffer, 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2BID
HUMAN PRO-APOPTOTIC PROTEIN BID
Deposited 1999-01-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–195(195 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;298 K;Pressure 1
|
Resolution not provided
|
|
2KBW
Solution Structure of human Mcl-1 complexed with human Bid_BH3 peptide
Deposited 2008-12-09
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
76–106(31 aa)
Fragment:BH3 motif, residues 76-106
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;303 K;Ionic strength (raw mmCIF value) 20;Pressure ambient
NMR sample composition
0.5 mM [U-95% 15N] Mcl-1-1, 0.5 mM Bid_BH3-2, 20 mM HEPES-3, 1 mM DTT-4, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM Mcl-1-5, 0.5 mM [U-95% 15N] Bid_BH3-6, 20 mM HEPES-7, 1 mM DTT-8, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-95% 13C; U-95% 15N] Mcl-1-9, 0.5 mM Bid_BH3-10, 20 mM HEPES-11, 1 mM DTT-12, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-95% 13C; U-95% 15N] Mcl-1-13, 0.5 mM Bid_BH3-14, 20 mM HEPES-15, 1 mM DTT-16, 100 % [U-100% 2H] D2O-17, 100% D2O | 100% D2O
NMR sample composition
0.5 mM Mcl-1-18, 0.5 mM [U-95% 13C; U-95% 15N] Bid_BH3-19, 20 mM HEPES-20, 1 mM DTT-21, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM Mcl-1-22, 0.5 mM [U-95% 13C; U-95% 15N] Bid_BH3-23, 20 mM HEPES-24, 1 mM DTT-25, 100 % [U-100% 2H] D2O-26, 100% D2O | 100% D2O
NMR sample composition
0.4 mM [U-95% 15N] Mcl-1-27, 0.4 mM Bid_BH3-28, 20 mM HEPES-29, 1 mM DTT-30, 6 mg/mL Pf1 phage-31, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM Mcl-1-32, 0.4 mM [U-95% 15N] Bid_BH3-33, 20 mM HEPES-34, 1 mM DTT-35, 8 mg/mL Pf1 phage-36, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2M5I
NMR structures of human apoptotic protein tBid in LPPG micelle
Deposited 2013-02-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
61–195(135 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.6;318 K;Ionic strength (raw mmCIF value) 0.1;Pressure ambient
NMR sample composition
0.5 mM [U-15N] tBid in LPPG micelle, 0.8 mM [U-13C; U-15N] tBid in LPPG micelle, 0.8 mM [U-100% 15N; U-80% 2H] tBid in LPPG micelle, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.0 mM [U-100% 13C; U-100% 15N] tBid in LPPG micelle, 100% D2O | 100% D2O
|
Resolution not provided
|
|
4BD2
Bax domain swapped dimer in complex with BidBH3
Deposited 2012-10-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
76–109(34 aa)
Fragment:RESIDUES 76-109
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.4 M SODIUM CITRATE, 0.1 M SODIUM CACODYLATE PH 5.75
|
Resolution 2.21 Å
R-free 0.227
|
|
4QVE
Crystal structure of Bcl-xL in complex with BID BH3 domain
Deposited 2014-07-14
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
76–109(34 aa)
Fragment:BID BH3, UNP RESIDUES 76-109
|
Not recorded
|
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 10.5;291 K;2.0M Ammonium Sulphate, 0.2M Lithium Sulphate, 0.1M CAPS pH 10.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.05 Å
R-free 0.224
|
|
4ZEQ
Crystal Structure of human BFL-1 in complex with tBid BH3 peptide, Northeast Structural Genomics Consortium Target HX9247
Deposited 2015-04-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
125–150(26 aa)
Fragment:UNP Residues 125-150
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;Sodium Malonate
|
Resolution 1.80 Å
R-free 0.239
|
|
4ZIG
Crystal Structure of core/latch dimer of Bax in complex with BidBH3mini
Deposited 2015-04-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
125–144(20 aa)
Fragment:BH3 motif
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, Sodium cacodylate
|
Resolution 2.20 Å
R-free 0.229
|
|
4ZII
Crystal Structure of core/latch dimer of BaxI66A in complex with BidBH3
Deposited 2015-04-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
122–155(34 aa)
Fragment:BH3 motif
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, sodium cacodylate
|
Resolution 2.19 Å
R-free 0.223
|
|
5AJJ
Crystal structure of variola virus virulence factor F1L in complex with human Bid BH3 domain
Deposited 2015-02-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
79–112(34 aa)
Fragment:UNP RESIDUES 79-112
|
Not recorded
|
GOL GLYCEROL × 2
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;1.8 M SODIUM ACETATE AND 0.1 M HEPES PH 6.5
|
Resolution 1.75 Å
R-free 0.208
|
|
7M5A
Crystal Structure of human BAK in complex with W3W5_BID
Deposited 2021-03-23
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
80–100(21 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;293 K;0.2 M Potassium Sodium tartrate, 20% PEG 3350
|
Resolution 1.50 Å
R-free 0.219
|
|
7M5B
Crystal Structure of human BAK in complex with M3W5_BID
Deposited 2021-03-23
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
80–100(21 aa)
|
Not recorded
|
CU COPPER (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 6.5;293 K;15% PEG 4000 0.2 M NaCl 0.1 MES 6.5
|
Resolution 1.85 Å
R-free 0.205
|
|
7M5B
Crystal Structure of human BAK in complex with M3W5_BID
Deposited 2021-03-23
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
80–100(21 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 6.5;293 K;15% PEG 4000 0.2 M NaCl 0.1 MES 6.5
|
Resolution 1.85 Å
R-free 0.205
|
|
7P33
Epstein-Barr virus encoded Bcl-2 homolog BHRF-1 in complex with Bid BH3 peptide
Deposited 2021-07-07
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
76–109(34 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4M Ammonium phosphate mono basic
|
Resolution 2.79 Å
R-free 0.274
|
|
7P33
Epstein-Barr virus encoded Bcl-2 homolog BHRF-1 in complex with Bid BH3 peptide
Deposited 2021-07-07
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
76–109(34 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4M Ammonium phosphate mono basic
|
Resolution 2.79 Å
R-free 0.274
|
|
7P33
Epstein-Barr virus encoded Bcl-2 homolog BHRF-1 in complex with Bid BH3 peptide
Deposited 2021-07-07
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
76–109(34 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4M Ammonium phosphate mono basic
|
Resolution 2.79 Å
R-free 0.274
|
|
7P33
Epstein-Barr virus encoded Bcl-2 homolog BHRF-1 in complex with Bid BH3 peptide
Deposited 2021-07-07
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain I
76–109(34 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4M Ammonium phosphate mono basic
|
Resolution 2.79 Å
R-free 0.274
|
|
7P33
Epstein-Barr virus encoded Bcl-2 homolog BHRF-1 in complex with Bid BH3 peptide
Deposited 2021-07-07
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain J
76–109(34 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.4M Ammonium phosphate mono basic
|
Resolution 2.79 Å
R-free 0.274
|